| CAS NO: | 2229047-91-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 生物活性 | Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency forCD20on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding toCD20on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell lymphoma[1][2]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 2229047-91-8 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com